We are live on ! Find out more
HR

Howe & Rusling Portfolio holdings

AUM $1.53B
1-Year Est. Return 21.45%
This Fund
S&P 500
This Quarter Est. Return
-10.75%
1 Year Est. Return
+21.45%
3 Year Est. Return
+66.11%
5 Year Est. Return
+83.74%
10 Year Est. Return
+259.21%
AUM
$789M
AUM Growth
-$76.5M
Cap. Flow
+$29.9M
Cap. Flow %
3.79%
Top 10 Hldgs %
27.06%
Holding
1,208
New
169
Increased
297
Reduced
314
Closed
91

Top Buys

Rank Stock Value
1
LOW icon
Lowe's Companies
LOW
+$6.75M
2
VWO icon
Vanguard FTSE Emerging Markets ETF
VWO
+$5.08M
3
AZN icon
AstraZeneca
AZN
+$4.62M
4
MDT icon
Medtronic
MDT
+$2.43M
5
BKNG icon
Booking.com
BKNG
+$2.36M

Top Sells

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$9.36M
2
TSN icon
Tyson Foods
TSN
+$4.6M
3
BAC icon
Bank of America
BAC
+$4.41M
4
HAS icon
Hasbro
HAS
+$3.88M
5
USB icon
US Bancorp
USB
+$3.09M

Sector Composition

Rank Sector Weight
1 Technology 13.04%
2 Healthcare 12.98%
3 Financials 11.5%
4 Consumer Staples 8.7%
5 Industrials 7.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GTIP icon
1101
Goldman Sachs Access Inflation Protected USD Bond ETF
GTIP
$295M
$0 ﹤0.01%
+1
New +$54
HIVE
1102
HIVE Digital Technologies
HIVE
$777M
– –
-200
Closed -$2K
HOOD icon
1103
Robinhood
HOOD
$83.4B
$0 ﹤0.01%
50
– –
HOOK
1104
DELISTED
HOOKIPA Pharma
HOOK
$0 ﹤0.01%
+20
New +$331
HRTX icon
1105
Heron Therapeutics
HRTX
$95.5M
$0 ﹤0.01%
+50
New +$201
HUBG icon
1106
HUB Group
HUBG
$2.91B
– –
-100
Closed -$4K
HUMA icon
1107
Humacyte
HUMA
$197M
– –
-200
Closed -$1K
HUT
1108
Hut 8
HUT
$10.4B
– –
-50
Closed -$1K
HYMB icon
1109
State Street SPDR Nuveen ICE High Yield Municipal Bond ETF
HYMB
$3.18B
– –
-400
Closed -$11K
IDYA icon
1110
IDEAYA Biosciences
IDYA
$3.47B
– –
-40
Closed –
ILF icon
1111
iShares Latin America 40 ETF
ILF
$3.82B
$0 ﹤0.01%
7
– –
IP icon
1112
International Paper
IP
$22.4B
– –
-60
Closed -$3K
ISTB icon
1113
iShares Core 1-5 Year USD Bond ETF
ISTB
$5.13B
– –
-124
Closed -$6K
ITRM
1114
DELISTED
Iterum Therapeutics
ITRM
$0 ﹤0.01%
33
– –
IVZ icon
1115
Invesco
IVZ
$14.1B
– –
-2,056
Closed -$47K
JEF icon
1116
Jefferies Financial Group
JEF
$13B
– –
-7
Closed –
KRBN icon
1117
KraneShares Global Carbon Strategy ETF
KRBN
$141M
– –
-50
Closed -$2K
LITE icon
1118
Lumentum
LITE
$64.3B
$0 ﹤0.01%
2
– –
LQD icon
1119
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$33B
– –
-118
Closed -$14K
LYRA
1120
DELISTED
LYRA THERAPEUTICS INC
LYRA
$0 ﹤0.01%
+2
New +$544
MARA icon
1121
Marathon Digital Holdings
MARA
$4.29B
– –
-90
Closed -$3K
MBB icon
1122
iShares MBS ETF
MBB
$39.1B
– –
-152
Closed -$15K
MBIO icon
1123
Mustang Bio
MBIO
$4.52M
$0 ﹤0.01%
1
– –
MGIC
1124
DELISTED
Magic Software Enterprises
MGIC
– –
-150
Closed -$3K
MGNX icon
1125
MacroGenics
MGNX
$248M
$0 ﹤0.01%
27
– –
43 44
45
46 47

Similar funds

SG
Sienna Gestion Paris, France $1.53B AUM 27.73% 1-Year Est. Return
FI
FJ Investments Salt Lake City, Utah $1.53B AUM 27.51% 1-Year Est. Return
MCP
Meridiem Capital Partners Dallas, Texas $1.53B AUM 17.03% 1-Year Est. Return
CCM
Cinctive Capital Management New York $1.53B AUM 48.83% 1-Year Est. Return
ICM
Irenic Capital Management New York $1.54B AUM 12.79% 1-Year Est. Return
CET
Clean Energy Transition London, United Kingdom $1.54B AUM 34.41% 1-Year Est. Return
AF
Atlas FRM Greenwich, Connecticut $1.53B AUM 14.94% 1-Year Est. Return
PAG
Private Advisory Group Redmond, Washington $1.52B AUM 41.01% 1-Year Est. Return

Howe & Rusling's Q2 2022 Portfolio in Review

As of Q2 2022, Howe & Rusling held 1,208 positions worth $789M, down 8.8% from $865M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Howe & Rusling deployed $29.9M of net new capital in Q2 2022, opening 169 new positions and adding to 297 existing holdings. Its largest new stake was AstraZeneca: 35,197 shares worth $4.65M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 14% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Berkshire Hathaway Class B, an estimated $9.36M trimmed.

  • Howe & Rusling's largest Q2 2022 buy was AstraZeneca: 35,197 shares worth $4.65M.
  • Howe & Rusling added most to Lowe's Companies in Q2 2022, an estimated $6.75M increase.
  • Howe & Rusling's biggest Q2 2022 reduction was Berkshire Hathaway Class B, cutting an estimated $9.36M.
  • Howe & Rusling fully exited Traeger in Q2 2022, selling an estimated $124K.
  • Howe & Rusling's ten largest holdings make up 27% of its $789M portfolio in Q2 2022.
  • Howe & Rusling opened 169 new positions and closed 91 in Q2 2022.
  • Howe & Rusling's portfolio value fell 8.8% quarter-over-quarter to $789M.

Based on Howe & Rusling's 13F filing for Q2 2022, filed 15 Aug 2022.